RVMD
USDRevolution Medicines Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$57.990
High
$59.680
Low
$57.740
Volume
2.37M
Company Fundamentals
Market Cap
10.9B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.19M
Exchange
NMS
Currency
USD
52-Week Range
Related News
RBC Capital Initiates Coverage On Revolution Medicines with Outperform Rating, Announces Price Target of $77
RBC Capital analyst Leonid Timashev initiates coverage on Revolution Medicines with a Outperform rating and announces Price Target of $77.
Revolution Medicines' RAS(ON) Multi-Selective Inhibitor Daraxonrasib Granted U.S. FDA Orphan Drug Designation in Pancreatic Cancer
REDWOOD CITY, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today
Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor
REDWOOD CITY, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today
Mizuho Initiates Coverage On Revolution Medicines with Outperform Rating, Announces Price Target of $90
Mizuho analyst Joseph Catanzaro initiates coverage on Revolution Medicines with a Outperform rating and announces Price Target of $90.
Related Stocks
GOODO
Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share
KIND
Nextdoor Holdings Inc.
HPK
HighPeak Energy Inc.
QTWO
Q2 Holdings Inc.
RVPH
Reviva Pharmaceuticals Holdings Inc.
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.